Literature DB >> 20455072

Severity as an independent determinant of the social value of a health service.

Jeff R J Richardson1, John McKie, Stuart J Peacock, Angelo Iezzi.   

Abstract

This paper has two objectives, first to review the relevant literature concerning the social importance of severity of pre-treatment condition, and second to present the results of a new analysis of the relationship between social value, individual assessment of health improvement and the severity of illness. The present study differs methodologically from others reported in the literature. The underlying hypothesis is that members of the public have an aversion to patients being in a severe health state irrespective of the reason for their being there, and that this aversion will affect the social valuation of a health program after taking account of the magnitude of the health improvement. This effect will be observable in a program which (compared to another) takes a person out of a severe health state--the usual case discussed in the literature--or in a program which (compared to another) leaves a person in a severe health state. The present study tests this second implication of the hypothesis. We present data consistent with the view that after taking account of health improvement, health programs are preferred which do not leave people in severe health states. Alternative explanations are considered and particularly the possibility that data reflect a social preference for individuals achieving their health potential. Both explanations imply the need to reconsider the rules for prioritizing programs. In this analysis, Person Trade-Off (PTO) scores are used to measure social preferences ('value' or 'social utility') and Time Trade-Off (TTO) scores are used to measure individual assessments of health improvement and initial severity. Econometric results suggest that severity is highly significant and may more than double the index of social value of a health service.

Entities:  

Mesh:

Year:  2010        PMID: 20455072     DOI: 10.1007/s10198-010-0249-z

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  28 in total

1.  Health state after treatment: a reason for discrimination?

Authors:  J M Abellan-Perpiñan; J L Pinto-Prades
Journal:  Health Econ       Date:  1999-12       Impact factor: 3.046

2.  Rationing fairly: programmatic considerations.

Authors:  Norman Daniels
Journal:  Bioethics       Date:  1993-04       Impact factor: 1.898

3.  The validity of a visual analogue scale in determining social utility weights for health states.

Authors:  E Nord
Journal:  Int J Health Plann Manage       Date:  1991 Jul-Sep

4.  Economic evaluation of services for a National Health scheme: the case for a fairness-based framework.

Authors:  Jeff Richardson; John McKie
Journal:  J Health Econ       Date:  2007-02-27       Impact factor: 3.883

5.  Health priorities and public preferences: the relative importance of past health experience and future health prospects.

Authors:  Paul Dolan; Aki Tsuchiya
Journal:  J Health Econ       Date:  2005-01-23       Impact factor: 3.883

6.  Equity, efficacy, and the point system for transplant recipient selection.

Authors:  D Wikler
Journal:  Transplant Proc       Date:  1989-06       Impact factor: 1.066

7.  Incorporating societal concerns for fairness in numerical valuations of health programmes.

Authors:  E Nord; J L Pinto; J Richardson; P Menzel; P Ubel
Journal:  Health Econ       Date:  1999-02       Impact factor: 3.046

8.  Lack of multiplicative transitivity in person trade-off responses.

Authors:  Michaël Schwarzinger; Jean-Louis Lanoë; Erik Nord; Isabelle Durand-Zaleski
Journal:  Health Econ       Date:  2004-02       Impact factor: 3.046

9.  Using the person trade-off approach to examine differences between individual and social values.

Authors:  P Dolan; C Green
Journal:  Health Econ       Date:  1998-06       Impact factor: 3.046

10.  Social evaluation of health care versus personal evaluation of health states. Evidence on the validity of four health-state scaling instruments using Norwegian and Australian surveys.

Authors:  E Nord; J Richardson; K Macarounas-Kirchmann
Journal:  Int J Technol Assess Health Care       Date:  1993       Impact factor: 2.188

View more
  4 in total

1.  Distribution-Weighted Cost-Effectiveness Analysis Using Lifetime Health Loss.

Authors:  Ulrikke J V Hernæs; Kjell A Johansson; Trygve Ottersen; Ole F Norheim
Journal:  Pharmacoeconomics       Date:  2017-09       Impact factor: 4.981

Review 2.  Stated and Revealed Preferences for Funding New High-Cost Cancer Drugs: A Critical Review of the Evidence from Patients, the Public and Payers.

Authors:  Tatjana E MacLeod; Anthony H Harris; Ajay Mahal
Journal:  Patient       Date:  2016-06       Impact factor: 3.883

Review 3.  A systematic review of stated preference studies reporting public preferences for healthcare priority setting.

Authors:  Jennifer A Whitty; Emily Lancsar; Kylie Rixon; Xanthe Golenko; Julie Ratcliffe
Journal:  Patient       Date:  2014       Impact factor: 3.883

4.  Comparing actuarial and subjective healthy life expectancy estimates: A cross-sectional survey among the general population in Hungary.

Authors:  Zsombor Zrubka; Áron Kincses; Tamás Ferenci; Levente Kovács; László Gulácsi; Márta Péntek
Journal:  PLoS One       Date:  2022-03-10       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.